{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:19:22Z","timestamp":1782951562948,"version":"3.54.5"},"reference-count":54,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,28]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) is a chronic autoimmune disease requiring long-term therapy, where adherence critically impacts outcomes. Non-adherence remains a significant barrier to disease control, particularly in China, where healthcare disparities persist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This scoping review aimed to systematically map the existing evidence on the frequency, barriers and facilitators of treatment adherence among Chinese patients with SLE and to identify gaps to guide future research and interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>We included studies that assessed adherence to pharmacological and\/or non-pharmacological SLE treatments among Chinese adults (\u226518 years). Eligible designs included observational, interventional, qualitative and mixed-method studies published in English or Chinese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Sources of evidence<\/jats:title>\n                    <jats:p>10 electronic databases (eg, CNKI, PubMed, Web of Science, SCOPUS) were searched from inception to 27 March 2024, using MeSH terms and relevant keywords. Additional studies were retrieved through manual reference screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Charting methods<\/jats:title>\n                    <jats:p>Data were extracted using a standardised form informed by the WHO multidimensional adherence framework. Key variables included study design, adherence measurement tools, frequency and categorised barriers\/facilitators. Data were charted independently by two reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>21 studies met inclusion criteria. Adherence was most often measured via self-report, especially Morisky Medication Adherence Scale-8 and Compliance Questionnaire for Rheumatology. Non-adherence ranged from 33.3% to 75.0%, reflecting measurement and population heterogeneity. Barriers were commonly patient-related, treatment-related and system-related, including fear of side effects, complex regimens, poor communication and financial burden. Facilitators included structured education, psychological support, simplified regimens and family support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment adherence among Chinese SLE patients is suboptimal and influenced by multidimensional factors. Culturally tailored, multilevel interventions\u2014addressing education, communication and system-level barriers\u2014are urgently needed. Adoption of standardised adherence measures and use of the WHO framework can improve cross-study comparability and guide targeted interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      OSF: osf.io\/x5uzc; DOI:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/GQWA7\">https:\/\/doi.org\/10.17605\/OSF.IO\/GQWA7<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-091845","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:15:15Z","timestamp":1755616515000},"page":"e091845","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Frequency, barriers and facilitators of adherence to treatment among people with systemic lupus erythematosus in China: a scoping review"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9677-3113","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"Macau University of Science and Technology, Taipa, Macau, China"},{"name":"Zhuhai College of Science and Technology, Zhuhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Feng","sequence":"additional","affiliation":[{"name":"The Fifth People\u2019s Hospital of Zhuhai, Zhuhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ying","sequence":"additional","affiliation":[{"name":"Macau University of Science and Technology, Taipa, Macau, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Peiyu","sequence":"additional","affiliation":[{"name":"The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[{"name":"Zunyi Medical University - Zhuhai Campus, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"2025123106470634000_15.8.e091845.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206334"},{"key":"2025123106470634000_15.8.e091845.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"2025123106470634000_15.8.e091845.3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/rir-2020-0009","article-title":"2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus","volume":"1","author":"Li","year":"2020","journal-title":"Rheumatol Immunol Res"},{"key":"2025123106470634000_15.8.e091845.4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025123106470634000_15.8.e091845.5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vhri.2023.03.007","article-title":"Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study","volume":"37","author":"He","year":"2023","journal-title":"Value Health Reg Issues"},{"key":"2025123106470634000_15.8.e091845.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762"},{"key":"2025123106470634000_15.8.e091845.7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025123106470634000_15.8.e091845.8","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000966","article-title":"Association of patient copayment and medication adherence in systemic lupus erythematosus","volume":"10","author":"Lomanto Silva","year":"2023","journal-title":"Lupus Sci Med"},{"key":"2025123106470634000_15.8.e091845.9","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2025123106470634000_15.8.e091845.10","unstructured":"World Health Organization . Adherence to long-term therapies: evidence for action. World Health Organization, 2003."},{"key":"2025123106470634000_15.8.e091845.11","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025123106470634000_15.8.e091845.12","first-page":"2469","article-title":"Low blood concentration of hydroxychloroquine is a marker for poor adherence in systemic lupus erythematosus: a cohort study","volume":"30","author":"Costedoat-Chalumeau","year":"2003","journal-title":"J Rheumatol"},{"key":"2025123106470634000_15.8.e091845.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2014.08.078","article-title":"The Reliability and Validity of the Chinese Version of the Eight-Item Morisky Medication Adherence Scale","volume":"17","author":"Ho","year":"2014","journal-title":"Value Health"},{"key":"2025123106470634000_15.8.e091845.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062775","article-title":"Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"2025123106470634000_15.8.e091845.15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/RHU.0000000000000952","article-title":"Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus","volume":"26","author":"Du","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2025123106470634000_15.8.e091845.16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2147\/PPA.S144624","article-title":"Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China","volume":"11","author":"Zhang","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"2025123106470634000_15.8.e091845.17","first-page":"3091","article-title":"A survey on treatment adherence in 195 patients with systemic lupus erythematosus","volume":"17","author":"Liu","year":"2019","journal-title":"Gen Practi Nurs"},{"key":"2025123106470634000_15.8.e091845.18","first-page":"1041","article-title":"Influencing factors of treatment adherence and humanistic care strategies in hospitalized patients with rheumatic diseases","volume":"35","author":"Li","year":"2022","journal-title":"Chinese Medical Ethics"},{"key":"2025123106470634000_15.8.e091845.19","first-page":"100","article-title":"Investigation on medication adherence and nursing strategies in patients with systemic lupus erythematosus","volume":"38","author":"Cheng","year":"2022","journal-title":"Chinese Community Doctors"},{"key":"2025123106470634000_15.8.e091845.20","unstructured":"Li S , Jin M . Analysis of factors affecting adherence to hormone application in patients with systemic lupus erythematosus and nursing care. Modern J Integrat Chinese Western Med 2008;17."},{"key":"2025123106470634000_15.8.e091845.21","unstructured":"Shi P . Influencing factors and prediction model construction and validation of medication adherence in patients with systemic lupus erythematosus. 2022."},{"key":"2025123106470634000_15.8.e091845.22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2147\/PPA.S169776","article-title":"Predictors of medication nonadherence in patients with systemic lupus erythematosus in Sichuan: a cross-sectional study","volume":"12","author":"Xie","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"2025123106470634000_15.8.e091845.23","first-page":"57","article-title":"Survey on the status of hormone therapy adherence and cognition in patients with systemic lupus erythematosus","volume":"18","author":"Zhou","year":"2012","journal-title":"J Qilu Nurs"},{"key":"2025123106470634000_15.8.e091845.24","first-page":"3","article-title":"Survey analysis of medication adherence in patients with systemic lupus erythematosus and countermeasures","volume":"2","author":"Chen","year":"2005","journal-title":"Attend Pract Res"},{"key":"2025123106470634000_15.8.e091845.25","first-page":"28","article-title":"Factors influencing adherence to medication in systemic lupus erythematosus and intervention measures","volume":"13","author":"Chen","year":"2015","journal-title":"J China Prescript Drug"},{"key":"2025123106470634000_15.8.e091845.26","unstructured":"Dong G , Shi H , Miao H . Investigation and analysis of adherence to glucocorticoids and factors affecting them in patients with systemic lupus erythematosus. J Shanxi Workers\u2019 Med College 2013;23."},{"key":"2025123106470634000_15.8.e091845.27","first-page":"2575","article-title":"Analysis of factors affecting medication adherence in patients with systemic lupus erythematosus","volume":"23","author":"Huang","year":"2010","journal-title":"Med Inform"},{"key":"2025123106470634000_15.8.e091845.28","first-page":"363","article-title":"Analysis of the causes of poor medication adherence in patients with systemic lupus erythematosus and nursing countermeasures","volume":"15","author":"Li","year":"2013","journal-title":"Chinese Comm Phys (Medical Specialty)"},{"key":"2025123106470634000_15.8.e091845.29","first-page":"244","article-title":"Prednisolone non-compliance and its related factors in patients with systemic lupus erythematosus","volume":"56","author":"Lin","year":"1995","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"2025123106470634000_15.8.e091845.30","first-page":"1029","article-title":"Observations on glucocorticoid compliance in patients with systemic lupus erythematosus","volume":"6","author":"Wang","year":"2006","journal-title":"Chinese Trop Med"},{"key":"2025123106470634000_15.8.e091845.31","first-page":"1243","article-title":"A survey of adherence to hormone therapy in patients with systemic lupus erythematosus","volume":"20","author":"Ying","year":"2006","journal-title":"Chinese Nurs Res"},{"key":"2025123106470634000_15.8.e091845.32","unstructured":"Zhang Y . A study on medication adherence and its influencing factors in children with long-term oral glucocorticoid therapy. 2017. Available: https:\/\/doi.org\/10.7666\/d.Y3277908"},{"key":"2025123106470634000_15.8.e091845.33","first-page":"186","article-title":"Analysis of psychological factors affecting medication adherence in patients with systemic lupus erythematosus and nursing intervention","volume":"23","author":"Zhu","year":"2015","journal-title":"Chinese Disa Med"},{"key":"2025123106470634000_15.8.e091845.34","unstructured":"Wang Z . A survey of treatment adherence and influencing factors in patients with systemic lupus erythematosus. Chongqing Med 2010;248."},{"key":"2025123106470634000_15.8.e091845.35","first-page":"256","article-title":"Analysis of drug-resistant psychology and nursing countermeasures in patients with systemic lupus erythematosus","volume":"35","author":"Wu","year":"2013","journal-title":"J Guiyang College Tradit Chinese Med"},{"key":"2025123106470634000_15.8.e091845.36","first-page":"2298","article-title":"Analysis of medication adherence and influencing factors in patients with systemic lupus erythematosus","volume":"29","author":"Zhou","year":"2008","journal-title":"Jilin Medical"},{"key":"2025123106470634000_15.8.e091845.37","first-page":"352","article-title":"Prevalence and associated factors of medication nonadherence among Thai patients with systemic lupus erythematosus","volume":"30","author":"Sae-Lim","year":"2021","journal-title":"Lupus (Los Angel)"},{"key":"2025123106470634000_15.8.e091845.38","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00296-021-04898-0","article-title":"Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population","volume":"41","author":"Hardy","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025123106470634000_15.8.e091845.39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jbspin.2020.04.017","article-title":"Adherence to hydroxychloroquine in patients with systemic lupus: Contrasting results and weak correlation between assessment tools","volume":"87","author":"Hachulla","year":"2020","journal-title":"Joint Bone Spine"},{"key":"2025123106470634000_15.8.e091845.40","first-page":"615","article-title":"Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey","volume":"33","author":"Emamikia","year":"2024","journal-title":"Lupus (Los Angel)"},{"key":"2025123106470634000_15.8.e091845.41","first-page":"753","article-title":"Compliance and persistence with hydroxychloroquine in South Korean patients with systemic lupus erythematosus","volume":"27","author":"Lee","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2025123106470634000_15.8.e091845.42","doi-asserted-by":"crossref","first-page":"2024doi","DOI":"10.3389\/flupu.2024.1461739","article-title":"Sub-optimal use of anti-malarial therapy for SLE in the Asia Pacific region: observations from the Asia Pacific lupus cohort","volume":"2","author":"Kandane-Rathnayake","year":"2024","journal-title":"Front Lupus"},{"key":"2025123106470634000_15.8.e091845.43","first-page":"1652","article-title":"Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort","volume":"27","author":"Chehab","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2025123106470634000_15.8.e091845.44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clicom.2023.10.001","article-title":"Challenges in the diagnosis and management of SLE in India","volume":"4","author":"Chatterjee","year":"2023","journal-title":"Clinical Immunology Communications"},{"key":"2025123106470634000_15.8.e091845.45","doi-asserted-by":"crossref","unstructured":"Kurita N , Oguro N , Miyawaki Y , et al . Trust in the attending rheumatologist, health-related hope, and medication adherence among japanese patients with systemic lupus erythematosus: the trump 2 -sle project. Rheumatology (Sunnyvale) 2022. doi:10.1101\/2022.07.06.22277337","DOI":"10.1101\/2022.07.06.22277337"},{"key":"2025123106470634000_15.8.e091845.46","first-page":"321","article-title":"Microelectronic systems for monitoring and enhancing patient compliance with medication regimens","volume":"49","author":"Cramer","year":"1995","journal-title":"Drugs (Abingdon Engl)"},{"key":"2025123106470634000_15.8.e091845.47","first-page":"137","article-title":"A qualitative study of facilitators of medication adherence in systemic lupus erythematosus: Perspectives from rheumatology providers\/staff and patients","volume":"33","author":"Herndon","year":"2024","journal-title":"Lupus (Los Angel)"},{"key":"2025123106470634000_15.8.e091845.48","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000720","article-title":"Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development","volume":"9","author":"Garg","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2025123106470634000_15.8.e091845.49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/PPA.S395928","article-title":"Capturing What Matters with Patients\u2019 Bypass Behavior? Evidence from a Cross-Sectional Study in China","volume":"17","author":"Xie","year":"2023","journal-title":"Patient Prefer Adherence"},{"key":"2025123106470634000_15.8.e091845.50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2478\/rir-2022-0006","article-title":"The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020","volume":"3","author":"Tian","year":"2022","journal-title":"Rheumatol Immunol Res"},{"key":"2025123106470634000_15.8.e091845.51","doi-asserted-by":"crossref","first-page":"2024doi","DOI":"10.3389\/flupu.2024.1462111","article-title":"Strengthening lupus education and coordinated care in developing countries","volume":"2","author":"Navarra","year":"2024","journal-title":"Front Lupus"},{"key":"2025123106470634000_15.8.e091845.52","doi-asserted-by":"crossref","unstructured":"Leung GM , Wagstaff A , Lindelow M , et al . China, hong kong and taiwan, health systems of. In: Heggenhougen HK , ed. International encyclopedia of public health. Academic Press, 2008: 656\u201371.","DOI":"10.1016\/B978-012373960-5.00305-1"},{"key":"2025123106470634000_15.8.e091845.53","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2643-6"},{"key":"2025123106470634000_15.8.e091845.54","unstructured":"Enabling Shared Decision-Making in Patients With Lupus, 2022. Available: https:\/\/media.primeinc.org\/upload\/programs\/13WB213\/Enabling%20Shared%20Decision-Making%20in%20Patients%20With%20Lupus.pdf"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-091845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:48:52Z","timestamp":1767192532000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-091845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2024-091845"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-091845","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}